A B S T R A C T Monocytes, macrophages, and neutrophils will demonstrate several important cellular functions in response to synthetic formylated oligopeptides. N-formyl-norleucyl-leucyl-phenylalanyl-norleucyl-tyrosyl-lysine (fNLPNTL) was a potent chemoattractant for human blood monocytes; a 1.0-nM concentration induced a maximal chemotactic response. Binding of 125I-labeled fNLPNTL to the monocyte formyl peptide receptor was rapid, specific, and saturable at 4, 24, or 37°C. At 4°C, monocytes from several different donors demonstrated between 10,000 and 18,000 receptors/ cell with a dissociation constant (&d) of 1.7-2.7 nM.
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The association of the 1251 peptide with the cells was irreversible at the elevated temperatures and exceeded the amount of surface receptor by approximately fourfold, suggesting receptor-mediated peptide endocytosis. Processing of rhodamine-labeled fNLPNTL by monocytes was observed directly by video intensification microscopy. At 37°C, diffuse membrane fluorescence was seen initially, followed by rapid aggregation and internalization of the peptide.
Monocytes incubated with fNLPNTL displayed a temperature dependent loss ofsurface binding capacity (receptor down-regulation). This decrease was due to a decrease in surface receptor number rather than to a decrease in receptor affinity. A dose-response curve for peptide-induced receptor down-regulation correlated with a dose-response curve for 125I-labeled fNLPNTL uptake, suggesting that each uptake event led to the loss ofone surface receptor. Surface receptor replenishment following down-regulation was rapid and not dependent on new protein synthesis, but was inversely INTRODUCTION Cells of the mononuclear phagocyte system (blood monocytes and tissue macrophages) play a major role in various physiologic and pathologic conditions including removal and catabolism of senescent or damaged erythrocytes (1) , "processing" of antigen for initiation of immune responses (2) , participation in inflammatory processes (3) , promotion of wound healing (4) , and mediation of host defense against microbes (5) and neoplastic cells (6) . Although all of these important cellular functions presumably are dependent on the ability of the mononuclear phagocyte to recognize various environmental stimuli at the plasma membrane, little is known about the molecular mechanisms of these recognition processes.
The movement of monocytes or macrophages to various tissue sites and sites of inflammation in vivo is thought to be influenced by various chemotactic substances including C5a, lymphokines, and bacterialderived factors (7, 8) . Neutrophil membrane receptors for molecularly defined N-formylated oligopeptides, which are believed to be synthetic analogues ofthe bacterial-derived factors, have been demonstrated, and factors modulating neutrophil chemotactic peptide binding have been studied (9) (10) (11) (12) (13) (14) . In this investigation, we characterize the receptor for the iodinated chemotactic peptide N-formyl-norleucyl-leucyl- fNLPNTL and N-formyl-methionyl-leucyl-phenylalanylmethionyl-tyrosine (fMLPMT) were synthesized as previously described (12) . fNLPNTL was radioiodinated by the chloramine T method (12) with specific radioactivities varying from 450 to 1,700 Ci/mmol among various samples. N-formyl-methionyl-leucyl-phenylalanine (fMLP) was obtained from Sigma Chemical Co. The peptides were prepared as 1-mM solutions in dimethylformamide (fNLPNTL) or dimethyl sulfoxide (fMLP or fMLPMT) and diluted in Gey's-BSA to 1 ,uM (unlabeled peptides) or 20 nM (labeled peptides) and frozen in aliquots at -20°C until use.
Isolation of monocytes. We obtained fresh peripheral blood monocytes from normal volunteers or patients after their informed consent according to a protocol approved by the Duke University Clinical Investigation Committee. The blood, anticoagulated with 10 U/ml heparin, was diluted 1:3 with PBS and layered over Ficoll-sodium diatrizoate, and the mononuclear cells were separated according to methods of Boyum (20) , with the modification of slow spins (60g) during the washing steps to decrease platelet contamination. After suspending the resulting mononuclear cells at 4 x 106/ml DMM, 0.1 ml was placed into 6-mm Diam chambers, and incubated for 2 h at 37°C in 5% C02/95% air to allow for monocyte adherence. The nonadherent cells were I Abbreviations used in this paper: DMM, supplemented Dulbecco's modified Eagle's medium; fMLP, N-formylmethionyl-leucyl-phenylalanine; fMLPMT, N-formyl-methionyl-leucyl-phenylalanyl-methionyl-tyrosine; fNLPNTL, N- formyl-norleucyl-leucyl-phenylalanyl-tyrosyl-lysine; Gey's-BSA, Gey's balanced salt solution with 2% bovine serum albumin; PBS, phosphate-buffered saline.
removed by washing the chambers twice with 0.2 ml PBS using suction through a Pasteur pipette. Usually, 70% of the adherent cells were esterase-and peroxidase-positive, ingested opsonized erythrocytes and polystyrene spheres, and were contaminated by 30% lymphocytes; also, two to four platelets per leukocyte remained after washing. Platelets and lymphocytes do not bind the chemotactic peptide (21) .
To more completely isolate monocytes from lymphocytes, the mononuclear cells obtained after processing with Ficollsodium diatrizoate were separated using a discontinuous Percoll gradient with a modification of a previously described technique (22) . 50 x 106 monocytes obtained from Ficollsodium diatrizoate gradients were incubated 20 min at 37°C with 2 nM 1251-labeled fNLPNTL (total) or 2 nM 1251-labeled fNLPNTL with 100 nM unlabeled fNLPNTL (nonsaturable), and washed three times with DMM. Then the cells, in a 0.5-ml PBS in a 15-ml centrifuge tube, were overlaid sequentially with 4 ml Percoll at specific gravity 1.126, 4 ml at specific gravity 1.067, and 2 ml at specific gravity 1.057. The tube was centrifuged at 420 g for 20 min at 4°C. Cells from the resulting bands were washed three times with PBS. The cell-associated 1251-labeled fNLPNTL was determined and specific peptide uptake was expressed as the difference between the total and nonsaturable values.
Binding assay. The standard binding assay was done in microtiter plates. The adherent cell layer was washed with PBS, and then 0.15 ml of the radiolabeled peptide (2 nM in Gey's-BSA unless otherwise noted) was placed directly onto the adherent cells. Replicate wells received mixtures of the radiolabeled peptide and saturating (100 nM) concentrations of the unlabeled peptide, so that nonsaturable binding could be determined for each experimental point. All assays were done in triplicate. The cells were incubated with the peptide for 2 h at the designated temperature, and then the adherent cells were aspirated from the microtiter chambers with a semiautomated multiple sample harvester, deposited onto filter paper, and washed with 20 vol of assay wash buffer. The filters were then counted in a gamma counter to determine cell-associated radioactivity. All data are presented as saturable binding, the difference between total and nonsaturable binding. Giemsa-stained cells in replicate wells were counted and binding was expressed as femtomoles bound per 105 adherent cells. Careful, uniform washing was necessary to lessen the variability in cell number per replicate chamber. In studies reported here, standard deviations of cell numbers in replicate chambers were <15% of the mean. In down-regulation experiments, the cells were incubated in suspension with the designated concentration of unlabeled fNLPNTL in protein-free DMM at 5 x 106 cells/ ml. They were then washed three times with cold DMM and used for subsequent recovery and binding assays. The binding assay was done in suspension with the cells at 5 x 106/ ml in 50% DMM/50% assay wash buffer with 0.1% BSA (12) .
Visualization of binding and uptake of the tetramethylrhodamine conjugate of fNLPNTL was done using video intensification microscopy as previously described (21) . Photographs were taken with a Polaroid camera (Polaroid Corp., Cambridge, Mass.) directly from the television monitor. Chemotaxis assays were done as previously described using polycarbonate filters with pores of 5 jiM Diam (23) . Measurement of leucine incorporation into trichloroacetic acidprecipitable monocyte material was done as described previously (24) .
RESULTS
Characteristics of 125I-formyl peptide binding and uptake by human monocytes. The synthetic oligo-peptide fNLPNTL is a potent chemoattractant for human neutrophils and differentiated human promyelocytic leukemia cells (HL-60) (12, 25) . Both cell types exhibit a maximal chemotactic response to a 1.0 nM concentration. fNLPNTL was also a potent chemoattractant for human monocytes, with a 1.0-nM concentration again inducing the maximal response ( Fig. 1) .
When human monocytes, either adherent to plastic or in suspension, were incubated with 2 nM 125I-labeled fNLPNTL, cell-associated radioactivity increased until a stable plateau was achieved (Fig. 2) . At 24 and 37°C, this plateau was reached in <1 h, whereas at 4°C, both the rate and extent of accumulation of cell-associated radioactivity was less. The plateau at 4°C was a true equilibrium, because cellassociated radioactivity could be removed by washing, whereas the plateau at 24°C was not, because the cellassociated radioactivity could not be displaced by washing or by the addition of a 50-fold excess of nonradioactive formyl peptide (Fig. 3) . The plateau at 24°C was not due simply to proteolytic destruction of 125I1 labeled fNLPNTL in solution, as had been demonstrated under similar incubation conditions with human neutrophils (12 (Fig. 6 ). Contaminating monocytes and neutrophils accounted for the small amount of uptake seen in the lymphocyte and erythrocyte fraction.
Fluorescent formyl peptide uptake. The inability to remove 1251-labeled fNLPNTL that had been bound at the higher temperatures suggested that the peptide had been internalized as had been previously shown with human and rabbit neutrophils (12, 14, 21) . A direct demonstration of receptor-mediated internalization was obtained using rhodamine-labeled fNLPNTL and video intensification microscopy (21) .
When adherent human monocytes were incubated with rhodamine-labeled fNLPNTL at 37°C and fixed at various timed intervals, the following sequence of events was determined. At 1 min, the fluorescent peptide was distributed in a diffuse pattern over the entire cell membrane (Fig. 7A) . By 3 min, the membrane-associated fluorescent peptide had begun to aggregate in the plane of the membrane, and by 15 min, it had been internalized within small endocytic vesicles that displayed the saltatory motion characteristic of cytoplasmic organelles (Fig. 7B, C (Fig. 8) . This phenomenon has been observed in many ligandreceptor systems and is termed down-regulation. Halfmaximal down-regulation was induced by 2 nM formyl peptide, with a plateau >10 nM. The percentage of maximal down-regulation induced by a given concentration of unlabeled peptide paralleled the percentage of maximal uptake measured with the same concentration of 1251-labeled fNLPNTL (see Fig. 4 ). Typically, 5-15% of the receptors were not down-regulated even after prolonged incubations with very high peptide J. B. Weinberg, J. J. Muscato, and J. E. Niedel concentrations (200-500 nM). This decrease in surface binding was temperature dependent. 11% of the surface receptors were down-regulated following a 1-h incubation at 4°C with 5 nM formyl peptide, whereas 80% of the receptors were down-regulated by 5 nM peptide within 15 min at 37°C. That the diminished binding capacity of down-regulated cells was primarily due to a decrease in functional surface receptors rather than to an altered receptor affinity is shown in Fig. 9 . Scatchard analysis demonstrated that although the total binding capacity of down-regulated cells was decreased to 5% of the control value (18,000 FIGURE 7 Internalization of rhodamine-labeled fNLPNTL by human blood monocytes. Frames a, b, and c show photographs of monocytes that were incubated with 2.5 nM rhodamine-labeled formyl peptide and fixed after 1, 3, and 15 min, respectively. At 1 min, the peptide was distributed diffusely over the entire membrane; at 3 min, the fluorescent peptide appeared as aggregates in the plane of the membrane; and at 15 min, it appeared in internalized vesicles. The magnifications on the TV monitor in (A) and (B) were 4,000, and 10,000 in (C).
receptors/control cell, 900 receptors/down-regulated cell), the dissociation constant (Kd) values were comparable (Kd = 1.7 nM for control cells, Kd = 1.1. nM for down-regulated cells). Receptor recovery after down-regulation. We next attempted to correlate this receptor loss with an alteration in the chemotactic response of the downregulated cells. Although the down-regulated cells always displayed diminished chemotaxis when compared with control cells, an exact correlation between extent of down-regulation and decrease in the chemotactic response was not found for any single experiment and poor reproducibility was evident between experiments. However, when the data from five experiments were combined, a correlation coefficient of r = 0.75 was obtained, suggesting that chemotactic receptor number may correlate with the magnitude of the chemotactic response (Fig. 10) . The variability evident in these experiments could be explained if receptor recovery were occurring during the 90-to 120-min incubation at 370C required for the chemotaxis assay, as had been shown for rabbit neutrophils (14) . The rate of receptor recovery at 370C is shown in Fig. 11 2-h recovery incubation. However, when these cells were then cultured overnight, 50% receptor recovery was seen at 8 h and complete recovery at 18 h. As can be seen from this figure, an exact correlation between the extent of down-regulation measured at 4°C at zero time and the chemotactic response measured at 37°C over a 90-120-min interval would not be expected because the receptor number per cell would be increasing during the chemotaxis assay. For example, in one experiment, cells treated with 2.8 nM peptide were 72% down-regulated at zero time, but displayed rapid receptor recovery and essentially normal chemotaxis. By contrast, cells treated with 280 nM peptide were down-regulated to a similar extent (85%) at zero time, but receptor recovery did not occur and their chemotactic response was inhibited 92%. The extent of receptor recovery after down-regulation was inversely related to the time of the incubation used to induce down-regulation (Fig. 12) . The receptor number on mononuclear cells was down-regulated to -l 10% of the control value by incubations of 15, 30, or 60 min at 37°C with 20 nM unlabeled fNLPNTL. However, when these cells were washed extensively and receptor recovery was assessed following a 60-min incubation at 37°C, cells down-regulated for 15 min recovered to 100% of control receptor number and cells down-regulated for 30 min recovered to 70% of control, whereas cells down-regulated to 60 min recovered to only 46% of the control value.
Receptor recovery appeared to be independent of new protein synthesis (Fig. 13 ). Cells were 88% downregulated with 20 nM fNLPNTL for 30 min at 37°C, washed extensively at 40C, and the time-course of receptor recovery was determined at 370C in the absence or presence of 3 ,ug/ml cycloheximide. This concentration of cycloheximide inhibited leucine incorporation into monocyte acid-precipitable material by 89% without affecting cell viability during a 2-h incubation. Receptor number per cell was identical at each time point in the presence or absence of cycloheximide. Although in the experiment depicted, receptor number per control cell remained essentially constant over the 60-min incubation at 37°C, in related experiments we frequently observed a 10-40% decrease in receptor number in the absence of peptide during a 60-min incubation.
DISCUSSION
As demonstrated here, the properties of the human blood monocyte receptor for chemotactic formyl peptides resemble the properties of the receptor on human and rabbit neutrophils and guinea pig macrophages (10-12, 14,26) . As determined at 40C, there are 10,000-18,000 surface receptors per cell that mediate the rapid internalization and specifically bound 1251-labeled fNLPNTL. The relative affinities of a small series of peptides correlated with their relative potencies as chemoattractants. Rhodamine-labeled fNLPNTL was initially bound in a relatively diffuse distribution over the cell surface, but the bound peptides rapidly aggregated in the plane of the plasma membrane and were internalized. Receptor-mediated binding, aggregation, and internalization appear to be universal mechanisms by which eukaryotic cells process polypeptide ligands (27) . The way in which the receptor itself is processed during peptide-binding and internalization is less clear. The number of surface receptors decreased following cell-peptide interactions at 37°C, but not at 4°C. The dose-response curve for this peptide-induced receptor down-regulation correlated closely with the dose-response curve for peptide uptake under the same conditions (Fig. 8) . This implies that for each peptide internalized, one surface receptor became unavailable for binding. A similar one-to-one relationship has been postulated for down-regulation of the formyl peptide receptor on rabbit neutrophils (14) , although other investigators found that receptor down-regulation exceeded peptide uptake (28) . The decrease in cell-surface binding appeared to be due to surface receptor loss rather than to a change in receptor affinity because half-maximal saturation of binding occurred at -2 nM for both the receptors on control cells and the receptors remaining on the down-regulated cells (Fig. 9) (Figs. 2 and 4) . This is not consistent with the simple hypothesis that each uptake event inactivates one surface receptor and implies that replenishment of functional surface receptors must occur. The term "replenishment" is used throughout in a functional sense, to denote the recovery of specific, saturable surface binding after receptor down-regulation, without implication as to mechanism. The data in Fig. 11 demonstrate that the receptors that were down-regulated by the binding event were subsequently replenished on the plasma membrane during a 37°C incubation. Moreover, the rate and perhaps extent ofrecovery appeared to depend on the peptide concentration used for induction of down-regulation. At (30) . Alternatively, a latent or cryptic pool of receptors may exist either intracellularly or on the membrane, which could be expressed after the inactivation of the original surface receptors. The latter two possibilities are supported by the observation that stimuli that cause lysosomal degranulation and requisite fusing of lysosomal membrane with plasma membrane can increase the amount of surface receptor (13, 31) . Additionally, treatment of rabbit neutrophils with several aliphatic alcohols, particularly n-butanol, increased the number of surface receptors by up to threefold, suggesting that latent receptors can be expressed on the membrane (32) . New protein synthesis did not appear to be involved in receptor recovery from down-regulation because inhibition of protein synthesis by cycloheximide did not alter replenishment of surface receptors (Fig. 13) .
However, the capacity for peptide endocytosis and receptor replenishment must be limited because a plateau was reached during a time-course of peptide uptake (Fig. 2) . If these processes were not limited, peptide uptake would be linear with time until the concentration of peptide in the medium were significantly decreased. Peptide depletion did not explain the plateau because sufficient native 1251-labeled fNLPNTL remained in the medium to yield normal uptake values when applied to fresh cells. The data in Fig. 12 demonstrate that the cellular capacity to replenish surface receptors decreased when the length of the incubation used to induce down-regulation was increased. Comparable receptor down-regulation was achieved by a 15-, 30-, or 60-min incubation with 20 nM fNLPNTL. Whereas the cells down-regulated for 15 min displayed complete receptor recovery during a subsequent 60-min incubation, only 50% receptor recovery occurred under identical conditions with cells down-regulated for 60 min. This time-dependent loss of the capacity to replenish down-regulated surface receptors, coupled with the intracellular degradation and release of the internalized peptides observed previously (12) , may explain the plateau and eventual decrease in cell-associated 1251-labeled fNLPNTL seen during the time-course of uptake experiments.
The biological relevance of the peptide-induced modulation of the human monocyte chemotactic receptor presented here or of similar receptor modulation demonstrated with human and rabbit neutrophils remains uncertain (12, 14, 28, 29) . Attenuation of several cellular responses (termed deactivation) including chemotaxis (33) , lysosomal enzyme release (34) and aggregation (34) is known to occur following exposure of phagocytic cells to the formyl peptides. The correlation between functional deactivation of monocyte chemotaxis and receptor down-regulation was inexact (Fig. 10) . However, in light of our new understanding of receptor down-regulation and recovery, these experiments were ill-conceived. Pretreated cells will partially recover from down-regulation during the chemotaxis assay, but the rate and extent of this recovery will vary depending on both the time of incubation and the peptide concentration used to induce down-regulation. Additionally, during the chemotactic response, the cells are exposed to a continuously increasing concentration of peptide attractant and therefore increasing receptor down-regulation is presumably occurring during the assay. The measured chemotactic response may well be a function of these minute-to-minute changes in receptor down-regulation and recovery and chemotactic deactivation may in fact be the functional correlate of this complex receptor modulation. At present, no techniques are available to measure and integrate all of these variables affecting receptor number during the prolonged incubations required for the Boyden chamber chemotaxis assay. Other, more rapid, functional assays such as degranulation (13, 31, 34, 35) or orientation (36, 37) would be more suitable for these correlative experiments. Vitkauskas et al. (28) were able to show that deactivation of the degranulation response of rabbit neutrophils paralleled receptor down-regulation, although the percent decrease in the biological response consistently exceeded the percent decrease in receptor number. Thus, deactivation, which could play an important part in controlling phagocyte responses to environmental stimuli in vivo, may be mediated only in part by receptor down-regulation.
